Pediatrics/Physical Medicine and Rehabilitation·Aurora, CO

University of Colorado

Allocate signal →Track an away here22-26 pooled · applicant-level
Step 2 invited
p10 – p90
Sample N
applicant rows
This cycle
no tracked aways yet
Match rate
no match data
J-1 visaCategoricalAcademic/Clinician Educator
Your fitUniversity of Colorado Program

Create a free profile to see your personalized fit

Get started
Contact
AK
Program Director
Amy Suzanne Kanallakan, MD, BS
Email director
MM
Program Coordinator
Morgan Mestas
Email coordinator
Training sites7 hospitals
  • 1
    Children's Hospital Colorado
    Aurora, CO
    Primary
  • 2
    University of Colorado School of Medicine
    Aurora, CO
    Sponsor
  • 3
    Rocky Mountain Regional VA Medical Center
    Denver, CO
    Participant
  • 4
    Denver Health Medical Center
    Denver, CO
    Participant
  • 5
    HCA HealthOne Swedish Medical Center
    Englewood, CO
    Participant
  • 6
    University of Colorado Hospital
    Aurora, CO
    Participant
  • 7
    Craig Hospital
    Englewood, CO
    Participant
Interview invites
Loading...
Score rangesinvited cohort

Step 2 CK data not available

Level 2 CE data not available

Interview rates
US MD
38%
US DO
23%
US IMG
0%
Non-US IMG
13%
Applicant origin
In-state
0%
Out-of-state
26%
Interview prepPediatrics/Physical Medicine and Rehabilitation
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add University of Colorado to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Pediatrics/Physical Medicine and Rehabilitation.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.